Study on the protective effect of Xiaoyaosan on corticosterone-induced PC12 injury model and its neuroprotective components

Sun Lu, Wu Yayun, Liu Lijuan, Zhao Ya, Li Xiong, Zhao Ruizhi, Hu Qiaohong

PDF(3382 KB)
PDF(3382 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (04) : 451-458. DOI: 10.13406/j.cnki.cyxb.003473
Basic research

Study on the protective effect of Xiaoyaosan on corticosterone-induced PC12 injury model and its neuroprotective components

Author information +
History +

Abstract

Objective To study the neuroprotective effect of Xiaoyaosan and its chemical composition，and to identify the active ingredients in Xiaoyaosan responsible for neuroprotection. Methods Xiaoyaosan was extracted using water，and the chemical composition of extract was analyzed using high-resolution mass spectrometry and liquid chromatography. Moreover，we prepared Xiaoyaosan-containing serum and established a corticosterone（CORT，400 μmol/L） -induced PC12 cell injury model to evaluate the impact of the drug-containing serum on the proliferation rate of PC12 cells. Then we used SIMCA software to analyze the correlations between cell proliferation rate and drug components to identify the compounds in Xiaoyaosan that may have neuroprotective effects. Results Compared with the model group，the drug-containing serum could reduce the cell injury induced by CORT and promote cell proliferation（P=0.000）. Analysis of liquid chromatography-mass spectrometry data in software showed that the main medicinal compounds were：paeoniflorin，glycyrrhizic acid，liquiritin，rosmarinic acid，gallic acid，2-phenylacetaldehyde，（15Z）-9，12，13-trihydroxy-15-octadecenoic acid，salvianolic acid B，and licorice saponin G2. The experimental results of individual compounds showed that phenylacetaldehyde was effective in neuroprotection（P=0.000）. Conclusion This research proves that Xiaoyaosan has neuroprotective effect. Fifty-five compounds were identified as potential ingredients involved in neuroprotection. Seven compounds，previously unreported and possessing potential neuroprotective properties，were identified in Xiaoyaosan. In addition，we demonstrate that phenylacetaldehyde has a neuroprotective effect，which has not been reported. The results of this study provide a reference for elucidating the material basis of the neuroprotective effect of Xiaoyaosan，and also provide data support for expanding the clinical application of Xiaoyaosan.

Key words

Xiaoyaosan / neuroprotective effect / chemical composition

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
Sun Lu , Wu Yayun , Liu Lijuan , et al . Study on the protective effect of Xiaoyaosan on corticosterone-induced PC12 injury model and its neuroprotective components. Journal of Chongqing Medical University. 2024, 49(04): 451-458 https://doi.org/10.13406/j.cnki.cyxb.003473

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis
1
丁竹松. 加味逍遥散的临床应用体会[J]. 大家健康（学术版），2014，8（8）：52-53．
Ding ZS. Clinical application experience of Jiawei Xiaoyao Powder[J]. Health，2014，8（8）：52-53．
本文引用 [1]
2
张明瑞，王　镁. 王镁教授运用富碘中药联合逍遥散加减治疗甲亢经验总结[J]. 亚太传统医药，2023，19（4）：129-133．
Zhang MR， Wang M. Summary of professor Wang Mei’s experience in treating hyperthyroidism with iodine-rich traditional Chinese medicine combined with Xiaoyao Powder[J]. Asia Pac Tradit Med，2023，19（4）：129-133．
本文引用 [1]
3
俞　芹. 临床应用逍遥散的体会[J]. 世界中医药，2009，4（1）：40-41．
Yu Q. Experience of clinical application of Xiaoyao Powder[J]. World Chin Med，2009，4（1）：40-41．
本文引用 [1]
4
Chen JB， Lei CF， Li XJ，et al. Research progress on classical traditional Chinese medicine formula Xiaoyaosan in the treatment of depression[J]. Front Pharmacol，2022，13：925514．
本文引用 [1]
5
石博宇，刘　蓉，饶志粒，等. 逍遥散对LPS所致大鼠神经损伤的保护作用机制[J]. 中国实验方剂学杂志，2019，25（5）：50-56．
Shi BY， Liu R， Rao ZL，et al. Neuroprotective effect and mechanism of Xiaoyaosan on lipopolysaccharide-induced nerve injury in rat[J]. Chin J Exp Tradit Med Formulae，2019，25（5）：50-56．
本文引用 [1]
6
张莹林，姚俊岩. 神经炎症在阿尔茨海默病中作用的研究进展[J]. 国际麻醉学与复苏杂志，2022，43（1）：90-94．
Zhang YL， Yao JY. Research advances of the role of neuroinflammation in Alzheimer’s disease[J]. Int J Anesthesiol Resusc，2022，43（1）：90-94．
本文引用 [1]
7
Nakamura T， Oh CK， Liao LJ，et al. Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer’s disease[J]. Science，2021，371（6526）：eaaw0843．
本文引用 [1]
8
杨厚增，赵鸿君，任　路. 中医对焦虑障碍证候的经典名方治疗及其机理研究[J]. 中华中医药学刊，2023：1-12.
Yang HZ， Zhao HJ， Ren L. A study on the treatment of anxiety disorders by classical Chinese medicine and its mechanism[J]. Chin Arch Tradit Chin Med，2023：1-12.
本文引用 [1]
9
吴佳佳，卞庆来，丁凤敏，等. 逍遥散抗抑郁作用的研究进展[J]. 中华中医药学刊，2023：1-11.
Wu JJ， Bian QL， Ding FM，et al. Research progress on antidepressant effect of Xiaoyaosan[J]. Chin Arch Tradit Chin Med，2023：1-11.
本文引用 [1]
10
张碧涛，李媛媛，辛泰然，等. 逍遥散治疗抑郁症的研究进展[J]. 中国实验方剂学杂志，2022，28（23）：273-282．
Zhang BT， Li YY， Xin TR，et al. Xiaoyaosan in treatment of depression：a review[J]. Chin J Exp Tradit Med Formulae，2022，28（23）：273-282．
11
刘加河，洪冠宇，纪春敏，等. 逍遥散治疗糖尿病合并抑郁症的疗效观察[J]. 糖尿病新世界，2018，21（10）：77-78，81．
Liu JH， Hong GY， Ji CM，et al. Observation on the therapeutic effect of Xiaoyao Powder on diabetes mellitus complicated with depression[J]. Diabetes N World，2018，21（10）：77-78，81．
12
李云开. 逍遥散加减治疗中风后抑郁症的临床疗效观察[J]. 中国医药指南，2013，11（31）：345-346．
Li YK. The observation of clinical effect of post stroke depression treated by appropriate[J]. Guide China Med，2013，11（31）：345-346．
13
李劲松. 晚期癌症患者治疗中逍遥散抗抑郁的疗效观察[J]. 医学理论与实践，2013，26（24）：3267-3268．
Li JS. Observation on antidepressant effect of Xiaoyaosan in the treatment of advanced cancer patients[J]. J Med Theory Pract，2013，26（24）：3267-3268．
本文引用 [1]
14
李琼锋，杜义斌，赵　义. 立论于肝脾同治研究逍遥散对老年性痴呆模型鼠行为学及神经可塑性的影响[J]. 世界中医药，2017，12（5）：1124-1127．
Li QF， Du YB， Zhao Y. Effect of Xiaoyao Powder on praxiology and neural plasticity in rats with Alzheimer’s diseases from simultaneous treatment in liver and spleen theory[J]. World Chin Med，2017，12（5）：1124-1127．
本文引用 [1]
15
富文俊，曹国平，富丽俊. 慢性应激触发帕金森病神经损伤的分子生物学机制及调肝方药逍遥散保护作用的探讨[J]. 时珍国医国药，2017，28（1）：239-242．
Fu WJ， Cao GP， Fu LJ. The study on molecular mechanism of chronic stress triggering Parkinson’s disease and the effect of Tiaogan compound[J]. Lishizhen Med Mater Med Res，2017，28（1）：239-242．
本文引用 [1]
16
More SV， Choi DK. Atractylenolide-I protects human SH-SY5Y cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death[J]. Int J Mol Sci，2017，18（5）：1012．
本文引用 [1]
17
Wu QL， Cheng YQ， Liu AJ，et al. Formononetin recovered injured nerve functions by enhancing synaptic plasticity in ischemic stroke rats[J]. Biochem Biophys Res Commun，2020，525（1）：67-72．
本文引用 [1]
18
Liang K， Ye Y， Wang Y，et al. Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway[J]. J Neurol Sci，2014，344（1/2）：100-104．
本文引用 [1]
19
Chen X， Zhang M， Ahmed M，et al. Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer’s disease in rats[J]. Saudi J Biol Sci，2021，28（8）：4232-4239．
本文引用 [1]
20
Zhu XB， Liu JK， Chen SJ，et al. Isoliquiritigenin attenuates lipopolysaccharide-induced cognitive impairment through antioxidant and anti-inflammatory activity[J]. BMC Neurosci，2019，20（1）：41．
本文引用 [1]
21
Ha SK， Moon E， Lee P，et al. Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo [J]. Neurochem Res，2012，37（7）：1560-1567．
本文引用 [1]
22
Que RF， Zheng JL， Chang ZH，et al. Dl-3-n-butylphthalide rescues dopaminergic neurons in Parkinson’s disease models by inhibiting the NLRP3 inflammasome and ameliorating mitochondrial impairment[J]. Front Immunol，2021，12：794770．
本文引用 [1]
23
Lin TY， Huang WJ， Wu CC，et al. Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats[J]. PLoS One，2014，9（2）：e88644．
本文引用 [1]
24
Huang LB， Huang KJ， Ning H. Autophagy induction by hispidulin provides protection against sevoflurane-induced neuronal apoptosis in aged rats[J]. Biomed Pharmacother，2018，98：460-468．
本文引用 [1]
25
Huang LB， Huang KJ， Ning H. Hispidulin prevents sevoflurane- Induced memory dysfunction in aged rats[J]. Biomed Pharmacother，2018，97：412-422．
本文引用 [1]

Comments

PDF(3382 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Journal of Chongqing Medical University, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉